Instrucciones de búsqueda:
* Filter the ENTIRE resource library: Choose a OR a to sort all resources.
* Choose Search Items : to filter one collection or perform complex queries.
* Choose Browse by Topic to search by one or more Topics.
Navegar por los elementos (21 total)
-
Autor: Ella, Raches, Siddharth Reddy, Harsh Jogdand, Vamshi Sarangi, Brunda Ganneru, Sai Prasad, Dipankar Das, Dugyala Raju, Usha Praturi, Gajanan Sapkal, Pragya Yadav, Prabhakar Reddy, Savita Verma, Chandramani Singh, Sagar Vivek Redkar, Chandra Sekhar…
Tema: Research
Tipo de elemento: Publicación
Fecha de actualización: 2021-03-08
Descripción: BBV152 is a whole-virion inactivated SARS-CoV-2 vaccine (3 μg or 6 μg) formulated with a toll-like receptor 7/8 agonist molecule (IMDG) adsorbed to alum (Algel). We previously reported findings from a double-blind, multicentre, randomised, controlled… -
Autor: National Institute of Allergy and Infectious Diseases [National Institutes of Health] NIH (NIAID)
Tema: Research
Tipo de elemento: Publicación
Fecha de actualización: 2019-01-04
Descripción: The 2014-2016 Ebola outbreak in West Africa was the largest in history, with nearly 28,700 cases and more than 11,300 deaths. As local and international healthcare workers responded to the outbreak, the U.S. National Institute of Allergy and… -
Autor: WHO Solidarity Trial Consortium
Tema: Research
Tipo de elemento: Publicación
Fecha de actualización: 2020-12-02
Descripción: World Health Organization expert groups recommended mortality trials of four repurposed antiviral drugs — remdesivir, hydroxychloroquine, lopinavir, and interferon beta-1a — in patients hospitalized with coronavirus disease 2019 (Covid-19). -
Autor: the ACTT-1 Study Group Members
Tema: Treatment & Care
Tipo de elemento: Publicación
Fecha de actualización: 2020-05-22
Descripción: Discussing "a double-blind, randomized, placebo-controlled trial of intravenous remdesivir in adults hospitalized with Covid-19 with evidence of lower respiratory tract involvement." -
Autor: Anise N Happi, Chinedu A Ugwu, Christian T Happi
Tema: Research
Tipo de elemento: Publicación
Fecha de actualización: 2019-04-15
Descripción: This article discusses how "real-time genomic viral sequencing and surveillance of human populations represents a simple and cost-effective method of mitigating outbreaks in countries and locations that are most at risk of infectious disease… -
Autor: Corri B Levine, Sami Vasistha, Caroline Croyle Persson, LuAnn R Larson, Christopher J Kratochvil, Aneesh K Mehta, Lindsay J Hicks, Abigail E Lowe, Mark G Kortepeter, Lauren M Sauer
Tema: Emergency Management
Tipo de elemento: Publicación
Fecha de actualización: 2022-05-31
Descripción: The need for well-controlled clinical trials is fundamental to advancing medicine. Care should be taken to maintain high standards in trial design and conduct even during emergency medical events such as an infectious disease outbreak. In 2020,… -
Autor: WHO
Tema: Infection Control
Tipo de elemento: Publicación
Fecha de actualización: 2019-04-12
Descripción: ABOUT THIS ANALYSIS: DRC’s national research institute, the Institut National pour la Recherche Biomedicale (INRB) and WHO have conducted a preliminary analysis of the data being collected from the ring vaccination protocol. The analysis summarized… -
Autor: Mbala-Kingebeni P, Aziza A, Di Paola N, Wiley MR, Makiala-Mandanda S, Caviness K, Pratt CB, Ladner JT, Kugelman JR, Prieto K, Chitty JA, Larson PA, Beitzel B, Ayouba A, Vidal N, Karhemere S, Diop M, Diagne MM, Faye M, Faye O, Aruna A, Nsio J, Mulangu…
Tema: Research
Tipo de elemento: Publicación
Fecha de actualización: 2019-04-15
Descripción: The real-time generation of information about pathogen genomes has become a vital goal for transmission analysis and characterisation in rapid outbreak responses. In response to the recently established genomic capacity in the Democratic Republic of… -
Autor: National Academies Press
Tema: Research
Tipo de elemento: Publicación
Fecha de actualización: 2017-04-12
Descripción: Table of Contents Front Matter i-xxvi Summary 1-18 1 Introduction 19-36 2 Conducting Clinical Research During an Epidemic 37-82 3 Assessment of Therapeutic Trials 83-112 4 Assessment of Vaccine Trials 113-154 5… -
Autor: U.S. Food and Drug Administration (FDA)
Tema: Research
Tipo de elemento: Guía
Fecha de actualización: 2018-08-13
Descripción: FDA CDER statisticians are designing trials with adaptive features to make clinical evaluation of new drug treatments more efficient and informative. (FDA)More information on the subject can be read here.